Company / Gross Margin
Sigyn Therapeutics, Inc. Gross Margin History
FY2015-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
75.1%
FY2019
5-year range
65.7% / 75.1%
FY2015-FY2019
Trend
+14.3%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 66.0% to 75.1% over the past 4 years.
Based on SEC 10-K filings.
75.1% in FY2019.
Improved from 66.0% to 75.1% over the past 4 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2019, gross margin increased 14.3% year-over-year.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | 75.1% | +14.3% |
| FY2018 | 65.7% | -0.4% |
| FY2015 | 66.0% | - |
As of FY2019 · SEC 10-K · Updated Jun 29, 2026